SOTIO Biotech: SOTIO Presents Preclinical Data from BOXR CAR-T Program and Trial Design of Phase 2 AURELIO-04 Study at SITC Annual Meeting

Findings on the mechanism of action from the BOXR CAR-T platform indicate improved metabolic function and preservation of early memory subsets of T cells SOTIO anticipates initiating first-in-human DUET-01

Related Keywords

United States ,Boston ,Massachusetts ,Cambridge ,Cambridgeshire ,United Kingdom ,Pratirodh Koirala ,Kostenloser Wertpapierhandel ,Michael Tattory ,Radek Spisek ,Richard Kapsa ,Merck Co Inc ,Lifesci Communications ,Society For Immunotherapy Of Cancer ,Biotech Inc ,Annual Meeting ,Drug Development Department ,Gustave Roussy Cancer ,Sotio ,Biotech ,Presents ,Reclinical ,Data ,Rom ,Foxr ,Program ,Trial ,Design ,Hase ,Aurelio ,Study ,Itc ,Nnual ,Meeting ,